In an interview with Pharmacy Times®, Sara Assaf, MD, assistant professor at the University of New Mexico, discussed key considerations when selecting biologic therapies for severe asthma, including patient factors, treatment characteristics,…
CHEST 2025: How Clinicians Can Optimize Biologic Therapy for Severe Asthma Management
